Anthony R. Absalom,
Keira P. Mason
Springer International Publishing
e druk, 2017
9783319476070
Total Intravenous Anesthesia and Target Controlled Infusions
A Comprehensive Global Anthology
Specificaties
Gebonden, blz.
|
Engels
Springer International Publishing |
2017
ISBN13: 9783319476070
Rubricering
Levertijd ongeveer 9 werkdagen
Gratis verzonden
Samenvatting
This is a comprehensive and authoritative presentation of total intravenous anesthesia (TIVA) and target controlled infusion (TCI). The editors’ international reputation has enabled them to recruit leading experts from around the world to write single-author chapters in their area of expertise. Total Intravenous Anesthesia and Target Controlled Infusions is the first multi-disciplinary, globally authored volume on the topic.
Providing a single source of information on all aspects of TIVA and TCI, from pharmacologic modeling and the pharmacology of intravenous anesthetic drugs to practical considerations in the clinical setting and the requirements of special populations, Total Intravenous Anesthesia and Target Controlled Infusions examines the debate about the risks and advantages of TIVA, analyze outcome studies, and provides guidance on creating a curriculum to teach TIVA and TCI.
Specificaties
ISBN13:9783319476070
Taal:Engels
Bindwijze:gebonden
Uitgever:Springer International Publishing
Inhoudsopgave
<p>CONTENTS</p>
<p> </p>
<p> </p>
<p>PART 1. INTRODUCTION/BACKGROUND</p>
<p> </p>
<p>1. When and How Did It All Begin? A Brief History of Intravenous Anesthesia</p>
<p>John Sear</p>
<p> </p>
<p>2. The Development and Regulation of Commercial Devices for Target - Controlled Drug Infusion</p>
<p>John B Glen</p>
<p> </p>
<p>3. The Memory Labyrinth: systems, processes and boundaries </p>
Robert A. Veselis<p></p>
<p> </p>
<p>4. Consciousness and Anaesthesia </p>
<p>Ram Adapa</p>
<p> </p>
<p>5. Mechanisms of Intravenous Anaesthetic Action</p>
Hugh C. Hemmings Jr and Karl F. Herold<p></p>
<p> </p>
<p> </p>
<p>PART 2. PRINCIPLES OF PHARMACOLOGICAL MODELING</p>
<p> </p>
<p>6. Basic Pharmacology: Kinetics and Dynamics for Dummies </p>
<p>Johan Raeder</p>
<p> </p>
<p>7. Pharmacokinetic-Pharmacodynamic Modelling of Anesthetic Drugs</p>
<p>Johannes Hans Proost</p>
<p> </p>
<p>8. Principles of Target Controlled Infusions</p>
<p>Steven L. Shafer</p>
<p> </p>
<p>9. Performance of Target-Controlled Infusion Systems</p>
<p>Matthew TV Chan</p>
<p> </p>
<p>10. How to Select a PK/PD Model</p>
<p>Kenichi Masui</p>
<p> </p>
<p> </p>
<p>PART 3. PHARMACOLOGY OF THE INTRAVENOUS ANESTHETIC AGENTS</p>
<p> </p>
<p>11. Propofol PK-PD</p>
<p>Douglas J. Eleveld</p>
<p>12. Etomidate and Etomidate Analogues: Molecular Pharmacology and Behavioral Actions</p>
<p>Douglas E. Raines</p>
<p> </p>
<p>13. Dexmedetomidine: The Science and Clinical Aspects in Adults and Children</p>
<p>Mohamed Mahmoud</p>
<p> </p>
<p>14. Clinical Effects and Applications of Ketamine</p>
<p>Mark G. Roback</p>
<p> </p>
<p>15. Neuromuscular Blocking Drugs: Pharmacology, Physiology and Clinical Aspects</p>
<p>Claude Meistelman</p>
16. New and Upcoming Drugs: Intravenous Anesthetic Agents <p>John William Sear</p>
<p> </p>
<p>17. Drug Interactions in Anesthesia</p>
<p> Jaap Vuyk</p>
<p> </p>
<p> </p>
<p> </p>
<p>PART 4. PRACTICAL CONDUCT OF SEDATION AND ANESTHESIA</p>
<p>18. Pumps Pitfalls and Practicalities</p>
<p>Frank Engbers</p>
<p> </p>
<p>19. EEG Monitoring of Depth of Anesthesia</p>
<p>Michael Sury</p>
<p> </p>
<p>20. Monitoring the analgesic component of anesthesia</p>
<p>Isabelle Constant<</p>
<p> </p>
<p>21. Intravenous Drugs for Sedation: Target Controlled, Patient Controlled, and Patient Maintained Delivery</p>
<p>Keith J Anderson and Gavin NC Kenny</p>
<p> </p>
<p>22. Pediatric TIVA/TCI: Case Presentations and Discussion </p>
Vivian Man-ying Yuen<p></p>
<p> </p>
<p>23. TCI/TIVA Adult Case Studies</p>
<p>Nicholas Sutcliffe</p>
<p> < </p><p> </p>
<p>PART 5. SPECIAL POPULATIONS AND PROCEDURES</p>
<p> </p>
<p>24. Intravenous Anesthesia in Obese Patients</p>
<p>Pablo Sepúlveda and Ignacio Cortínez </p>
<p> </p>
<p>25. Pharmacokinetics and Dynamics on the Pediatric Population</p>
<p>Brian J. Anderson</p>
<p> </p>
<p>26. Clinical Pharmacology of Intravenous Sedation in Children</p>
<p>Oliver Bagshaw</p>
<p></p>
<p>27. Sedation of the Critically Ill Child</p>
<p>Arno Brouwers, Sanne Vaassen, Gijs D Vos, Jan NM Schieveld, and Piet L Leroy</p>
<p> </p>
<p>28. TCI & TIVA for Neurosurgery: Considerations and Techniques</p> <p>Massimo Lamperti and Fazil Ashiq</p>
<p> </p>
<p>29. TCI in Special Patients Groups: The Elderly and Obese</p>
<p>Frederique S Servin</p>
<p> </p>
<p>30. TIVA for Cardiac Surgery</p>
<p>Stefan Schraag</p>
<p> </p>
<p>31. TIVA/TCI in Veterinary Practice</p>
<p>Thierry Beths</p>
<p> </p>
<p> </p>
<p>PART 6. OUTCOME, EDUCATION, SAFETY, AND THE FUTURE</p>
<p> </p>
<p>32. Advantages, Disadvantages, and Risks of TIVA/TCI</p>
<p>Ken B Johnson</p>
<p> </p>
<p>33. Economics of TIVA</p>
<p>Jane Montgomery and Mary Stocker</p>
<p></p>
<p>34. Teaching TCI with Human Patient Simulators</p>
<p>Wolfgang Heinrichs</p>
<p> </p>
<p>35. Closed-Loop or Automated Titration of Intravenous Anesthesia: Background, Science and Clinical Impact</p>
<p>Ngai Liu </p>
<p> </p>
<p>36. Health Care Technology, the Human-Machine Interface, and Patient Safety During Intravenous Anesthesia</p>
<p>Craig S. Webster</p>
<p> </p>
<p>37. Can IV Sedatives Affect Outcome?</p>
<p>Christopher G. Hughes, Christina J. Hayhurst, and Pratik P. Pandharipande</p>
<p> </p>
<p>38. The Benefit and Future of Pharmacogenetics</p>
<p>Janko Samardzic, Dubravka Svob Strac, and John N. van den Anker </p>
<p> </p>
<p>39. Lessons from drug interaction displays</p>
<p>Ross Kennedy</p>
<p> </p>
<p>40. The Role of Intravenous Agents in Delirium</p>
<p>Claudia Spies, Susanne Koch, Alissa Wolf, Rudolf Mörgeli, and Björn Weiss</p>
<p> </p>
<p>41. Perioperative Cardioprotective Strategies in Noncardiac Surgery</p>
<p>Stefan De Hert</p>
<p> </p>
<p>42. Opioid Induced Hyperalgesia after Surgery: Clinical Relevance</p>
<p>Dr. Philippe Richebe</p>
<p> </p>
<p>43. Memory, Awareness and Intravenous Anaesthetics </p>
<p>Michael Wang </p>
<p> </p>
<p>44. Awareness and Dreaming During TIVA</p>
<p>Kate Leslie</p>
<p> </p>
<p>45. Apoptosis and Neurocognitive Effects of Intravenous Anesthetics </p>
<p>Sulipicio Soriano and Laszlo Vutskits</p>
<p> </p>
<p> </p>
<p>Epilogues </p>
<p> </p>
<p> </p>
<p>PART 1. INTRODUCTION/BACKGROUND</p>
<p> </p>
<p>1. When and How Did It All Begin? A Brief History of Intravenous Anesthesia</p>
<p>John Sear</p>
<p> </p>
<p>2. The Development and Regulation of Commercial Devices for Target - Controlled Drug Infusion</p>
<p>John B Glen</p>
<p> </p>
<p>3. The Memory Labyrinth: systems, processes and boundaries </p>
Robert A. Veselis<p></p>
<p> </p>
<p>4. Consciousness and Anaesthesia </p>
<p>Ram Adapa</p>
<p> </p>
<p>5. Mechanisms of Intravenous Anaesthetic Action</p>
Hugh C. Hemmings Jr and Karl F. Herold<p></p>
<p> </p>
<p> </p>
<p>PART 2. PRINCIPLES OF PHARMACOLOGICAL MODELING</p>
<p> </p>
<p>6. Basic Pharmacology: Kinetics and Dynamics for Dummies </p>
<p>Johan Raeder</p>
<p> </p>
<p>7. Pharmacokinetic-Pharmacodynamic Modelling of Anesthetic Drugs</p>
<p>Johannes Hans Proost</p>
<p> </p>
<p>8. Principles of Target Controlled Infusions</p>
<p>Steven L. Shafer</p>
<p> </p>
<p>9. Performance of Target-Controlled Infusion Systems</p>
<p>Matthew TV Chan</p>
<p> </p>
<p>10. How to Select a PK/PD Model</p>
<p>Kenichi Masui</p>
<p> </p>
<p> </p>
<p>PART 3. PHARMACOLOGY OF THE INTRAVENOUS ANESTHETIC AGENTS</p>
<p> </p>
<p>11. Propofol PK-PD</p>
<p>Douglas J. Eleveld</p>
<p>12. Etomidate and Etomidate Analogues: Molecular Pharmacology and Behavioral Actions</p>
<p>Douglas E. Raines</p>
<p> </p>
<p>13. Dexmedetomidine: The Science and Clinical Aspects in Adults and Children</p>
<p>Mohamed Mahmoud</p>
<p> </p>
<p>14. Clinical Effects and Applications of Ketamine</p>
<p>Mark G. Roback</p>
<p> </p>
<p>15. Neuromuscular Blocking Drugs: Pharmacology, Physiology and Clinical Aspects</p>
<p>Claude Meistelman</p>
16. New and Upcoming Drugs: Intravenous Anesthetic Agents <p>John William Sear</p>
<p> </p>
<p>17. Drug Interactions in Anesthesia</p>
<p> Jaap Vuyk</p>
<p> </p>
<p> </p>
<p> </p>
<p>PART 4. PRACTICAL CONDUCT OF SEDATION AND ANESTHESIA</p>
<p>18. Pumps Pitfalls and Practicalities</p>
<p>Frank Engbers</p>
<p> </p>
<p>19. EEG Monitoring of Depth of Anesthesia</p>
<p>Michael Sury</p>
<p> </p>
<p>20. Monitoring the analgesic component of anesthesia</p>
<p>Isabelle Constant<</p>
<p> </p>
<p>21. Intravenous Drugs for Sedation: Target Controlled, Patient Controlled, and Patient Maintained Delivery</p>
<p>Keith J Anderson and Gavin NC Kenny</p>
<p> </p>
<p>22. Pediatric TIVA/TCI: Case Presentations and Discussion </p>
Vivian Man-ying Yuen<p></p>
<p> </p>
<p>23. TCI/TIVA Adult Case Studies</p>
<p>Nicholas Sutcliffe</p>
<p> < </p><p> </p>
<p>PART 5. SPECIAL POPULATIONS AND PROCEDURES</p>
<p> </p>
<p>24. Intravenous Anesthesia in Obese Patients</p>
<p>Pablo Sepúlveda and Ignacio Cortínez </p>
<p> </p>
<p>25. Pharmacokinetics and Dynamics on the Pediatric Population</p>
<p>Brian J. Anderson</p>
<p> </p>
<p>26. Clinical Pharmacology of Intravenous Sedation in Children</p>
<p>Oliver Bagshaw</p>
<p></p>
<p>27. Sedation of the Critically Ill Child</p>
<p>Arno Brouwers, Sanne Vaassen, Gijs D Vos, Jan NM Schieveld, and Piet L Leroy</p>
<p> </p>
<p>28. TCI & TIVA for Neurosurgery: Considerations and Techniques</p> <p>Massimo Lamperti and Fazil Ashiq</p>
<p> </p>
<p>29. TCI in Special Patients Groups: The Elderly and Obese</p>
<p>Frederique S Servin</p>
<p> </p>
<p>30. TIVA for Cardiac Surgery</p>
<p>Stefan Schraag</p>
<p> </p>
<p>31. TIVA/TCI in Veterinary Practice</p>
<p>Thierry Beths</p>
<p> </p>
<p> </p>
<p>PART 6. OUTCOME, EDUCATION, SAFETY, AND THE FUTURE</p>
<p> </p>
<p>32. Advantages, Disadvantages, and Risks of TIVA/TCI</p>
<p>Ken B Johnson</p>
<p> </p>
<p>33. Economics of TIVA</p>
<p>Jane Montgomery and Mary Stocker</p>
<p></p>
<p>34. Teaching TCI with Human Patient Simulators</p>
<p>Wolfgang Heinrichs</p>
<p> </p>
<p>35. Closed-Loop or Automated Titration of Intravenous Anesthesia: Background, Science and Clinical Impact</p>
<p>Ngai Liu </p>
<p> </p>
<p>36. Health Care Technology, the Human-Machine Interface, and Patient Safety During Intravenous Anesthesia</p>
<p>Craig S. Webster</p>
<p> </p>
<p>37. Can IV Sedatives Affect Outcome?</p>
<p>Christopher G. Hughes, Christina J. Hayhurst, and Pratik P. Pandharipande</p>
<p> </p>
<p>38. The Benefit and Future of Pharmacogenetics</p>
<p>Janko Samardzic, Dubravka Svob Strac, and John N. van den Anker </p>
<p> </p>
<p>39. Lessons from drug interaction displays</p>
<p>Ross Kennedy</p>
<p> </p>
<p>40. The Role of Intravenous Agents in Delirium</p>
<p>Claudia Spies, Susanne Koch, Alissa Wolf, Rudolf Mörgeli, and Björn Weiss</p>
<p> </p>
<p>41. Perioperative Cardioprotective Strategies in Noncardiac Surgery</p>
<p>Stefan De Hert</p>
<p> </p>
<p>42. Opioid Induced Hyperalgesia after Surgery: Clinical Relevance</p>
<p>Dr. Philippe Richebe</p>
<p> </p>
<p>43. Memory, Awareness and Intravenous Anaesthetics </p>
<p>Michael Wang </p>
<p> </p>
<p>44. Awareness and Dreaming During TIVA</p>
<p>Kate Leslie</p>
<p> </p>
<p>45. Apoptosis and Neurocognitive Effects of Intravenous Anesthetics </p>
<p>Sulipicio Soriano and Laszlo Vutskits</p>
<p> </p>
<p> </p>
<p>Epilogues </p>